AXIM BIOTECHNOLOGIES, INC. Impairment of Intangible Assets, Finite-lived
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Impairment of Intangible Assets, Finite-lived of -$641.10 thousand for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2021-08-23
- AXIM BIOTECHNOLOGIES, INC. impairment of intangible assets, finite-lived for the quarter ending 2021-06-30 was -$641.10K.
- AXIM BIOTECHNOLOGIES, INC. impairment of intangible assets, finite-lived for the quarter ending 2015-12-31 was $0.00.
- AXIM BIOTECHNOLOGIES, INC. impairment of intangible assets, finite-lived for the quarter ending 2014-12-31 was $0.00.
- AXIM BIOTECHNOLOGIES, INC. impairment of intangible assets, finite-lived for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- AXIM BIOTECHNOLOGIES, INC. impairment of intangible assets, finite-lived for fiscal 2015 was $652.26K.
- AXIM BIOTECHNOLOGIES, INC. impairment of intangible assets, finite-lived for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- AXIM BIOTECHNOLOGIES, INC. impairment of intangible assets, finite-lived for fiscal 2013 was $30.00K.
| Period end | Impairment of Intangible Assets, Finite-lived 3 month | Impairment of Intangible Assets, Finite-lived 9 month | Impairment of Intangible Assets, Finite-lived 12 month | Impairment of Intangible Assets, Finite-lived 37 month | Impairment of Intangible Assets, Finite-lived 40 month |
|---|---|---|---|---|---|
| 2021-06-30 | -$641.10K 10-Q · filed 2021-08-23 | ||||
| 2016-12-31 | $0.00 10-K · filed 2017-09-14 | ||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-14 | $652.26K 10-K · filed 2017-09-14 | |||
| 2015-09-30 | $652.26K 10-Q · filed 2015-11-23 | ||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-18 | $0.00 10-K · filed 2016-04-18 | |||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-23 | ||||
| 2014-03-31 | $30.00K 10-Q · filed 2014-06-18 | ||||
| 2013-12-31 | $30.00K 10-K · filed 2014-03-04 | $30.00K 10-K · filed 2014-03-04 |